A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project

BACKGROUND: There have been no major advances in tuberculosis (TB) drug development since the first East African/British Medical Research Council short course chemotherapy trial 35 years ago. Since then, the landscape for conducting TB clinical trials has profoundly changed with the emergence of HIV...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Merle, Corinne SC, Sismanidis, Charalambos, Sow, Oumou Bah, Gninafon, Martin, Horton, John, Lapujade, Olivier, Lo, Mame Bocar, Mitchinson, Denis A, Perronne, Christian, Portaels, Francoise, Odhiambo, Joseph, Olliaro, Piero, Rustomjee, Roxana, Lienhardt, Christian, Fielding, Katherine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Methodology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528451/
https://ncbi.nlm.nih.gov/pubmed/22607233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-13-61
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak